• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Gene-regulatory factors shown to improve pancreatic cancer response to chemotherapy

Bioengineer by Bioengineer
August 1, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Department of Molecular Cytogenetics,TMDU

Tokyo, Japan – Pancreatic cancer is a particularly devastating disease because of the difficulty of identifying it at an early stage, and the difficulty of treating it when discovered at a late stage. Although various treatment options such as surgery, radiotherapy, and chemotherapy are available, the mortality rate remains extremely high, so efforts are increasingly being targeted at improving its detection and treatment.

In a study reported recently in the journal Scientific Reports, a team centered at Tokyo Medical and Dental University (TMDU) identified two molecules that can improve the response of pancreatic cancer to a common chemotherapy drug and also predict the prognosis of pancreatic cancer patients. These findings could pave the way to novel combined treatments for this disease.

Tumors can develop and spread via various processes, one of which is the epithelial-mesenchymal transition (EMT). In this transition, cells lose the ability to adhere strongly to each other, enabling them to disperse and invade tissues, where they can become established and multiply. In this new study, researchers employed a cell-based reporter system to screen a collection of over 1000 gene-regulatory factors called microRNAs for the ability to influence this transition and identified some with particularly potent effects.

"Our system is based around a molecule called E-cadherin, which suppresses tumor growth in part by maintaining cells in an epithelial rather than a mesenchymal state," Tomoki Muramatsu of TMDU says. "Using this system, we can visualize the expression of a fluorescent protein and monitor the transcriptional activity from the E-cadherin promoter region as fluorescent intensity, allowing the screening of EMT-suppressive miRNAs." (Figure 1).

The team narrowed down the approximately 1000 microRNAs to a handful that induced strong fluorescence in the system, and then reduced these to two that they confirmed could increase E-cadherin expression in pancreatic cancer cells. Their associations with pancreatic cancer were then confirmed by measuring their levels in 24 pancreatic cancer cell lines, which were lower than in normal cells, suggesting their tumor-suppressive functions.

"When we analyzed these microRNAs in more detail, we found that they reduced cancer cell migration and invasion by targeting genes related to EMT, essentially preventing or reversing this," Johji Inazawa says. "This effect was particularly interesting when it was observed alongside the effect of the chemotherapy drug gemcitabine. When these microRNAs were administered, gemcitabine was much more effective at killing cancer cells."

The findings suggest that therapies combining these microRNAs and gemcitabine could improve our ability to treat pancreatic cancer, and measurement of microRNA levels could also provide a guide to the prognosis in such cases.

###

The article "miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer" was published in Scientific Reports at doi: 10.1038/s41598-017-04191-w.

Media Contact

Johji Inazawa
[email protected]

http://www.tmd.ac.jp/english/

Original Source

http://www.tmd.ac.jp/english/press-release/20170801e/index.html http://dx.doi.org/10.1038/s41598-017-04191-w

Share12Tweet7Share2ShareShareShare1

Related Posts

Nurses’ Insights on Implementing Patient-Reported Outcomes

October 5, 2025

Exploring NK Cell Therapies for Solid Tumors

October 5, 2025

Acupuncture Use for Low Back Pain in China

October 5, 2025

Strong-Field Laser Passivation Cuts Stainless Steel Corrosion

October 5, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    91 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nurses’ Insights on Implementing Patient-Reported Outcomes

Exploring NK Cell Therapies for Solid Tumors

Acupuncture Use for Low Back Pain in China

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.